Skip to main content
Open Access Publications from the University of California

HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials

  • Author(s): Volk, JE
  • Hessol, NA
  • Gray, GE
  • Kublin, JG
  • Churchyard, G
  • Mlisana, K
  • Nchabeleng, M
  • Buchbinder, SP
  • Bekker, L
  • et al.
Main Content
Current View